Uganda Cancer Institute Achieves Milestone with Stem Cell Transplant

David Bongomin Awany, a 56-year-old businessman, was on the verge of traveling to India for a critical autologous stem cell transplant to treat multiple myeloma, a type of blood cancer. However, a conversation with Dr. Henry Dungu, a senior haematologist at the Uganda Cancer Institute (UCI), changed his plans.

Dr. Dungu informed Awany that the complex procedure could be performed at the UCI in Kampala. This offered Awany the opportunity to receive treatment in his home country, a choice he readily embraced, opting to stay and trust the local medical team.

Awany’s successful transplant makes him the second Ugandan to undergo this specialized treatment domestically. An autologous stem cell transplant involves collecting a patient’s own stem cells and reintroducing them to aid in treating diseases like multiple myeloma, where abnormal cells disrupt bone marrow function and blood cell production.

Previously, Ugandans requiring such advanced procedures had no option but to seek treatment overseas. Awany recounted his initial fear but ultimately found comfort in the care provided by the UCI’s doctors and nurses, who he says worked diligently throughout his treatment.

His positive experience has led him to advocate for increased investment in Ugandan medical specialists and equipment, suggesting that with adequate resources, local healthcare can achieve remarkable results. He noted his own recovery, moving from a wheelchair to walking, as a testament to the care received.

The UCI is experiencing a surge in patient numbers, with over 8,700 new cases registered in 2025. This growing demand, coupled with the institute’s expansion into more complex treatments, highlights the need for both advanced medical facilities and preventative health measures. Health Minister Dr. Chris Baryomunsi emphasized the importance of early screening and public awareness to improve treatment outcomes.

The government is also working to decentralize specialized cancer care, aiming to establish regional cancer services to reduce the burden on Kampala and minimize the need for patients to travel abroad. UCI Chairperson Professor Damalie Nakanjako and Dr. Dungu both hailed the successful transplant as a victory for the institute and for Uganda, demonstrating the potential of sustained investment in technology and human capital.

UCI plans to extend its transplant program to include other blood-related cancers such as lymphoma and certain leukaemias as its capacity grows.

https://observer.ug/news/cancer-institute-performs-stem-cell-transplant